🇺🇸 FDA
Patent

US 10377798

Recombinant respiratory syncytial virus G protein fragments

granted A61KA61K2039/525A61K2039/53

Quick answer

US patent 10377798 (Recombinant respiratory syncytial virus G protein fragments) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Aug 08 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Aug 13 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 08 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K2039/525, A61K2039/53, A61K2039/575, A61K39/155